Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MALATO, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.232
EU - Europa 2.807
AS - Asia 1.947
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 64
AF - Africa 57
OC - Oceania 2
Totale 9.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.149
SG - Singapore 698
IT - Italia 672
CN - Cina 532
RU - Federazione Russa 509
DE - Germania 392
FI - Finlandia 340
UA - Ucraina 285
BR - Brasile 220
HK - Hong Kong 188
VN - Vietnam 172
GB - Regno Unito 130
PL - Polonia 104
IE - Irlanda 94
SE - Svezia 91
FR - Francia 80
JP - Giappone 78
KR - Corea 52
IN - India 50
BD - Bangladesh 33
CA - Canada 33
BE - Belgio 32
AR - Argentina 24
TR - Turchia 24
IQ - Iraq 20
EC - Ecuador 18
MX - Messico 17
CI - Costa d'Avorio 16
CO - Colombia 16
VE - Venezuela 16
ZA - Sudafrica 14
NL - Olanda 13
RO - Romania 13
ES - Italia 12
UZ - Uzbekistan 12
AT - Austria 11
ID - Indonesia 11
IR - Iran 11
MA - Marocco 11
PK - Pakistan 10
CR - Costa Rica 9
PY - Paraguay 8
CL - Cile 7
JM - Giamaica 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 5
HN - Honduras 5
MY - Malesia 5
PH - Filippine 5
CH - Svizzera 4
EE - Estonia 4
EU - Europa 4
GR - Grecia 4
GT - Guatemala 4
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
TH - Thailandia 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EG - Egitto 3
NP - Nepal 3
QA - Qatar 3
TN - Tunisia 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
JO - Giordania 2
MD - Moldavia 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 9.363
Salva come PNG Salva come JPEG
Città #
Ashburn 584
Singapore 465
San Jose 340
Fairfield 261
Chandler 244
Woodbridge 182
Hong Kong 180
Ann Arbor 160
Wilmington 160
Jacksonville 152
Houston 140
Council Bluffs 122
Palermo 121
Seattle 106
Dublin 93
Frankfurt am Main 91
Zgierz 89
Cambridge 88
Beijing 86
Moscow 79
Tokyo 77
Medford 68
Nanjing 66
Santa Clara 66
Ho Chi Minh City 59
New York 57
Des Moines 54
Boardman 52
Los Angeles 51
Princeton 45
Dearborn 42
Hanoi 42
Hefei 38
Tulsa 38
Altamura 34
The Dalles 33
Dallas 31
Lauterbourg 31
Brussels 30
Orem 28
Helsinki 26
Lawrence 26
São Paulo 25
Milan 20
Nanchang 20
Shenyang 20
Tianjin 20
Buffalo 19
Chicago 19
San Diego 19
Abidjan 16
Jinan 16
Regensburg 16
Stockholm 16
Bremen 14
Changsha 14
Seongnam 14
Brooklyn 13
Kumar 13
Rome 13
Denver 12
Hebei 12
Izmir 12
Ludwigshafen am Rhein 12
Guayaquil 11
Phoenix 11
Verona 11
Washington 11
Zhengzhou 11
Atlanta 10
Columbus 10
Ningbo 10
San Mateo 10
Warsaw 10
Amsterdam 9
Brasília 9
Guangzhou 9
Jiaxing 9
London 9
Napoli 9
Newark 9
North Bergen 9
Nuremberg 9
Rio de Janeiro 9
Shanghai 9
Tehran 9
Auburn Hills 8
Chennai 8
City of London 8
Poplar 8
Baghdad 7
Haiphong 7
Hangzhou 7
Johannesburg 7
Kunming 7
Lanzhou 7
San José 7
Springfield 7
Turku 7
Cardiff 6
Totale 5.406
Salva come PNG Salva come JPEG
Nome #
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica 698
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. 359
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 340
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. 297
Successful Treatment of Gastrointestinal Bleeding With Recombinant Factor VIIa After Kidney Transplantation in Patients With Pancytopenia. 268
Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management 255
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study 244
Peri-operative bridgning therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy 232
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 230
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis 230
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. 228
Deferral of assessment of pulmonary embolism 228
Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation 227
Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. 226
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 219
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study 217
PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY 208
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS 203
Gastrointestinal bleeding in patients with von Willebrand disease; how long we can wait for surgery? 202
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study 202
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins 198
La profilassi chirurgica di pazienti con carenza congenita di FVII 197
THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE 196
The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease 191
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. 184
Evaluation of patients with thrombotic stroke by methionine loading oral curve 183
Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk 180
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. 179
The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. 179
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 178
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial 177
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. 174
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis 170
Uso del FVIIa ricombinante nell'emorragia gastrica post trapianto renale 167
ISAM: international study on anticoagulation management. The Italian experience 164
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia 163
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis 162
Successful treatment of acquired haemophilia with FEIBA and Retuximab 158
Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus 144
Prognostic relevance of an asymptomatic venous thromboembolism in patients with cance 144
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial 137
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT 129
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial 124
Thrombophilia in women with unexplained fetal loss 122
Un caso di emorragia gastrica post-trapianto di rene 109
Totale 9.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022349 0 0 0 34 14 13 23 15 65 81 21 83
2022/2023670 67 107 16 92 83 107 36 52 68 2 31 9
2023/2024362 9 48 37 55 26 72 44 14 3 7 5 42
2024/2025699 23 29 5 81 41 16 44 32 48 72 114 194
2025/20263.111 224 104 167 273 338 450 329 288 191 564 74 109
2026/2027862 113 103 440 206 0 0 0 0 0 0 0 0
Totale 9.422